Eyal Shamir

802 total citations
21 papers, 616 citations indexed

About

Eyal Shamir is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Eyal Shamir has authored 21 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Cognitive Neuroscience and 3 papers in Molecular Biology. Recurrent topics in Eyal Shamir's work include Schizophrenia research and treatment (9 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Face Recognition and Perception (2 papers). Eyal Shamir is often cited by papers focused on Schizophrenia research and treatment (9 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Face Recognition and Perception (2 papers). Eyal Shamir collaborates with scholars based in Israel and United States. Eyal Shamir's co-authors include Yoram Barak, Nava Zisapel, Avner Elizur, Ronit Weizman, Abraham Weizman, Vadim S. Rotenberg, Moshe Laudon, Marnina Swartz, Dan J. Stein and Ilona Mirecki and has published in prestigious journals such as Molecular Psychiatry, Psychiatry Research and The Journal of Clinical Psychiatry.

In The Last Decade

Eyal Shamir

21 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyal Shamir Israel 14 222 171 148 134 127 21 616
Ken Inada Japan 17 262 1.2× 128 0.7× 118 0.8× 42 0.3× 49 0.4× 78 763
Kazuki Honda Japan 13 167 0.8× 236 1.4× 92 0.6× 112 0.8× 45 0.4× 28 555
Cathrine Petersen United States 13 277 1.2× 254 1.5× 122 0.8× 80 0.6× 124 1.0× 22 770
E. S. Gershon United States 11 170 0.8× 116 0.7× 97 0.7× 60 0.4× 33 0.3× 17 562
Horst Gann Germany 18 126 0.6× 458 2.7× 389 2.6× 115 0.9× 51 0.4× 35 879
Steve Mann Canada 17 684 3.1× 99 0.6× 108 0.7× 77 0.6× 83 0.7× 25 1.1k
A. Viggiano Italy 17 59 0.3× 256 1.5× 151 1.0× 274 2.0× 35 0.3× 31 673
Makoto Okuya Japan 12 282 1.3× 107 0.6× 130 0.9× 60 0.4× 26 0.2× 32 596
Gillin Jc United States 15 184 0.8× 220 1.3× 167 1.1× 118 0.9× 32 0.3× 35 652

Countries citing papers authored by Eyal Shamir

Since Specialization
Citations

This map shows the geographic impact of Eyal Shamir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Shamir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Shamir more than expected).

Fields of papers citing papers by Eyal Shamir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Shamir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Shamir. The network helps show where Eyal Shamir may publish in the future.

Co-authorship network of co-authors of Eyal Shamir

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Shamir. A scholar is included among the top collaborators of Eyal Shamir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Shamir. Eyal Shamir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shamir, Eyal, et al.. (2020). Methadone maintenance treatment and survival of schizophrenic patients with a lifetime comorbid substance use disorders: a long-term follow-up study. Journal of Addictive Diseases. 38(4). 458–464. 3 indexed citations
2.
Jahshan, Carol, et al.. (2017). Probing the magnocellular and parvocellular visual pathways in facial emotion perception in schizophrenia. Psychiatry Research. 253. 38–42. 21 indexed citations
3.
Cassan, Stanley M., et al.. (2017). Clinical utility of biomarkers of the hand in the diagnosis of schizophrenia. Psychiatry Research. 260. 105–110. 6 indexed citations
4.
5.
Bedwell, Jeffrey S., et al.. (2013). The magnocellular visual pathway and facial emotion misattribution errors in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 44. 88–93. 20 indexed citations
6.
Shamir, Eyal, et al.. (2013). Biometric parameters of the hand as an index of schizophrenia—A preliminary study. Psychiatry Research. 210(3). 716–720. 6 indexed citations
7.
Baruch, Kuti, Gilad Silberberg, Eyal Shamir, et al.. (2009). Association between golli-MBP and schizophrenia in the Jewish Ashkenazi population: are regulatory regions involved?. The International Journal of Neuropsychopharmacology. 12(7). 885–885. 17 indexed citations
8.
Iancu, Iulian, et al.. (2004). The Positive and Negative Symptoms Questionnaire: a self-report scale in schizophrenia. Comprehensive Psychiatry. 46(1). 61–66. 21 indexed citations
9.
Barak, Yoram, Eyal Shamir, Ilona Mirecki, Ronit Weizman, & Dov Aizenberg. (2004). Switching elderly chronic psychotic patients to olanzapine. The International Journal of Neuropsychopharmacology. 7(2). 165–169. 14 indexed citations
10.
Barak, Yoram, et al.. (2002). Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(6). 1199–1202. 31 indexed citations
11.
Barak, Yoram, Eyal Shamir, & Ronit Weizman. (2002). Would a Switch From Typical Antipsychotics to Risperidone Be Beneficial for Elderly Schizophrenic Patients? A Naturalistic, Long-Term, Retrospective, Comparative Study. Journal of Clinical Psychopharmacology. 22(2). 115–120. 39 indexed citations
12.
Shamir, Eyal. (2001). Melatonin Treatment for Tardive Dyskinesia. Archives of General Psychiatry. 58(11). 1049–1049. 112 indexed citations
13.
Shamir, Eyal, et al.. (2000). Is Melatonin Treatment Effective for Tardive Dyskinesia?. The Journal of Clinical Psychiatry. 61(8). 556–558. 37 indexed citations
14.
Shamir, Eyal, Moshe Laudon, Yoram Barak, et al.. (2000). Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia. The Journal of Clinical Psychiatry. 61(5). 373–377. 101 indexed citations
15.
Shamir, Eyal, Vadim S. Rotenberg, Moshe Laudon, Nava Zisapel, & Avner Elizur. (2000). First-Night Effect of Melatonin Treatment in Patients With Chronic Schizophrenia. Journal of Clinical Psychopharmacology. 20(6). 691–694. 30 indexed citations
16.
Shamir, Eyal, Sanjiv Ghanshani, Robert Kimhi, et al.. (1999). hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Molecular Psychiatry. 4(3). 254–260. 65 indexed citations
17.
Barak, Yoram, Marnina Swartz, Eyal Shamir, Dan J. Stein, & Abraham Weizman. (1998). Vitamin E (α-Tocopherol) in the Treatment of Tardive Dyskinesia: A Statistical Meta-Analysis. Annals of Clinical Psychiatry. 10(3). 101–105. 34 indexed citations
18.
Rapoport, A., Dan J. Stein, Eyal Shamir, et al.. (1998). Clinico-tremorgraphic features of neuroleptic-induced tremor. International Clinical Psychopharmacology. 13(3). 115–120. 6 indexed citations
19.
Barak, Yoram, Marnina Swartz, Eyal Shamir, Dan J. Stein, & Abraham Weizman. (1998). Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.. Annals of Clinical Psychiatry. 10(3). 101–105. 37 indexed citations
20.
Garty, Moshe, Eyal Shamir, David Ilfeld, Silvio Pitlik, & Joseph B. Rosenfeld. (1986). Noninteraction of Digoxin and Nifedipine in Cardiac Patients. The Journal of Clinical Pharmacology. 26(4). 304–305. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ken Inada Breakdown of academic impact, for papers by Kazuki Honda Breakdown of academic impact, for papers by Cathrine Petersen Breakdown of academic impact, for papers by E. S. Gershon Breakdown of academic impact, for papers by Horst Gann Breakdown of academic impact, for papers by Steve Mann Breakdown of academic impact, for papers by A. Viggiano Breakdown of academic impact, for papers by Makoto Okuya Breakdown of academic impact, for papers by Gillin Jc
Rankless by CCL
2026